Overview
Stable bradyarrhythmia, characterized by a persistently slow heart rate, is a condition that requires careful monitoring and management, particularly in athletes where physical activity significantly influences heart rate dynamics. Understanding the impact of physical activity on heart rate variability is crucial for accurate diagnosis and effective management. This guideline synthesizes evidence from various studies to provide clinicians with a comprehensive approach to handling stable bradyarrhythmia, focusing on pathophysiology, clinical presentation, diagnostic considerations, management strategies, and potential complications.
Pathophysiology
The pathophysiology of stable bradyarrhythmia involves disruptions in the normal conduction pathways of the heart, leading to a reduced heart rate that does not typically fluctuate significantly under resting conditions. Spectral analysis in healthy subjects has shown that both random and rhythmic physical activities markedly increase RR interval variability and power below 0.03 Hz, indicating a substantial impact of physical activity on heart rate dynamics [PMID:8796109]. This variability is essential for maintaining cardiovascular efficiency and responding to physiological demands. However, in individuals with bradyarrhythmias, this natural variability may be diminished or altered, complicating the assessment of cardiac function during different activity levels. In clinical practice, recognizing these dynamics is crucial for distinguishing between normal variability and pathological states.
Physical activity not only influences heart rate but also affects the autonomic nervous system's modulation of heart rate, which can further complicate the interpretation of heart rate variability (HRV) in patients with bradyarrhythmias. Higher activity levels naturally increase HRV in healthy individuals, potentially masking underlying bradyarrhythmic patterns [PMID:8796109]. Therefore, clinicians must consider recent activity levels when evaluating patients, ensuring that assessments are not confounded by the inherent variability introduced by physical exertion.
Clinical Presentation
Patients with stable bradyarrhythmia often present with nonspecific symptoms such as fatigue, dizziness, and syncope, which can be exacerbated by physical activity. The study demonstrating the impact of physical activity on RR variability underscores the importance of contextualizing patient symptoms within their activity patterns [PMID:8796109]. For instance, athletes may experience these symptoms more acutely during training or competition, necessitating a nuanced approach to symptom evaluation.
Physical activity levels can significantly confound the interpretation of HRV, making it challenging to differentiate between normal physiological responses and pathological bradyarrhythmias. Clinicians should inquire about recent exercise routines and correlate symptom onset with activity intensity to refine diagnostic assessments. This contextual information is vital for accurate clinical judgment and to avoid misattributing symptoms solely to bradyarrhythmia without considering the broader physiological context.
Diagnosis
Diagnosing stable bradyarrhythmia requires precise measurement of heart rate and rhythm, particularly in athletes where physical activity can introduce significant variability. Commercial wrist-worn wearables, while convenient, often exhibit reduced accuracy during higher-intensity exercise and transient states, which can be critical for monitoring bradyarrhythmias [PMID:41157371]. These inaccuracies can lead to false negatives or positives, underscoring the need for complementary diagnostic tools.
To enhance diagnostic accuracy, advanced signal processing techniques such as the Fourier decomposition method (FDM) have shown promise. FDM effectively suppresses motion artifacts in photoplethysmography (PPG) signals without requiring additional reference signals, thereby improving heart rate estimations with lower Mean Absolute Error (MAE) and Percentage Absolute Error (PAE) values compared to conventional methods [PMID:34952340]. This method's high sensitivity (97.9%) and accuracy (93.8%) in evaluating PPG signal quality are particularly beneficial for diagnosing bradyarrhythmias in athletes during exercise, ensuring reliable monitoring [PMID:30440438]. Clinicians should consider integrating such advanced algorithms into their diagnostic protocols to mitigate the limitations of wearable devices.
Given the substantial impact of physical activity on RR variability, diagnostic criteria for bradyarrhythmias should incorporate recent activity levels to ensure a comprehensive and accurate assessment. This approach helps in distinguishing between normal physiological responses and pathological bradyarrhythmic patterns, thereby guiding appropriate clinical interventions [PMID:8796109].
Management
Managing stable bradyarrhythmia in athletes requires a multifaceted approach, balancing the need for continuous monitoring with the limitations of current wearable technology. While devices like Fitbit, Garmin, Apple Watch, and Polar offer convenience, their varying accuracy, especially during physical transitions and high-intensity activities, necessitates complementary diagnostic tools [PMID:41157371]. Clinicians should advocate for the integration of clinically validated monitoring systems alongside wearable devices to ensure comprehensive data collection.
Technological advancements, such as computationally efficient algorithms for real-time heart rate (HR) estimation, can be seamlessly integrated into wearable health monitoring devices [PMID:34952340]. These algorithms support continuous monitoring, which is essential for timely detection of bradyarrhythmic events and facilitating prompt adjustments in management strategies. Continuous monitoring allows for proactive interventions, reducing the risk of complications and enhancing patient outcomes.
For definitive treatment, first-generation leadless pacemakers provide a promising alternative to traditional transvenous pacemakers. These devices offer safe and efficient single-chamber pacing therapy without the need for transvenous leads, potentially reducing complications associated with lead and pocket-related issues [PMID:31657945]. Clinicians should consider leadless pacemakers as a viable option for patients requiring long-term pacing support, especially in athletic populations where minimizing complications is paramount.
Ensuring high-quality PPG signal collection through advanced methods, such as similarity-based signal processing techniques, enhances the reliability of monitoring bradyarrhythmic events [PMID:30440438]. This reliability is crucial for making informed clinical decisions and tailoring management plans to individual patient needs, particularly in the dynamic environment of athletic performance.
Complications
The management of stable bradyarrhythmia carries inherent risks, particularly with invasive pacing solutions. Traditional transvenous pacemaker therapy is associated with significant complications, many of which are related to the pacemaker leads and the implantation site (pocket complications) [PMID:31657945]. These complications can include infection, lead dislodgement, and thrombosis, posing substantial risks to patient safety and quality of life.
In contrast, leadless pacemakers represent a significant advancement by minimizing these risks. By eliminating the need for transvenous leads, these devices reduce the likelihood of lead-related complications and improve overall patient outcomes [PMID:31657945]. However, clinicians must remain vigilant for any emerging complications specific to leadless devices, ensuring ongoing surveillance and timely intervention when necessary.
Key Recommendations
By adhering to these recommendations, clinicians can provide more precise and effective care for patients with stable bradyarrhythmia, particularly in the challenging context of athletic performance and physical activity.
References
1 Van Oost CN, Masci F, Malisse A, Schyvens AM, Peters B, Dirix H et al.. Accuracy of Heart Rate Measurement Under Transient States: A Validation Study of Wearables for Real-Life Monitoring. Sensors (Basel, Switzerland) 2025. link 2 Pankaj, Kumar A, Komaragiri R, Kumar M. Reference signal less Fourier analysis based motion artifact removal algorithm for wearable photoplethysmography devices to estimate heart rate during physical exercises. Computers in biology and medicine 2022. link 3 Beurskens NEG, Breeman KTN, Dasselaar KJ, Meijer AC, Quast ABE, Tjong FVY et al.. Leadless cardiac pacing systems: current status and future prospects. Expert review of medical devices 2019. link 4 Jang DG, Kwon UK, Yoon SK, Park C, Ku Y, Noh SW et al.. A Simple and Robust Method for Determining the Quality of Cardiovascular Signals Using the Signal Similarity. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2018. link 5 Bernardi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovascular research 1996. link00081-8)
5 papers cited of 10 indexed.